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Abstract
Background: The mechanism of aluminum-induced neurotoxicity is not clear. The involvement
of glutamate in the aluminium-induced neurocomplications has been suggested. Brain glutamate
levels also found to be altered in protein malnutrition. Alterations in glutamate levels as well as
glutamate-α -decarboxylase in different regions of rat brain has been reported in response to
aluminum exposure. Thus the study of glutamate metabolising enzymes in different brain regions
o f  r a t s  m a i n t a i n e d  o n  e i t h e r  n o r m a l  o r  r e s t r i c t e d  p r o t e i n  d i e t  m a y  b e  o f  i m p o r t a n c e  f o r
understanding the neurotoxicity properties of aluminium.
Results: Dietary protein restrictions does not have an significant impact on regional aluminum
content of the brain. The interaction of aluminum intoxication and protein restriction is significant
in the thalamic area and the midbrain-hippocampal region in cases of glutamate oxaloacetate
transaminase. In the case of gluatmate pyruvate transaminase, this interaction is significant only in
thalamic area.
Conclusion: The metabolism of amino acids, as indicated by activities of specific transaminases, of
brain is altered in response to aluminum exposure. These alterations are region specific and are
dependent on dietary protein intake or manipulation of the brain amino acid homeostasis.
Background
The ubiquity of numerous aluminum compounds found
in soil, water and air ensure that we live in an aluminum-
rich environment. The entrance aluminum to human
body is carefully refrained; however, the metal gains ac-
cess to the body. The so-called 'biological inertness' and
other chemical properties of aluminum render maximum
use of this metal in our every day living. The toxic conse-
quences in human after aluminum exposure are now well
established [1,2]. The brain is the most sensitive organ to
show aluminum-induced disorders [3]. Despite several
hypotheses, the mechanism of aluminum-induced neuro-
toxicity is not clear [4,5]. There are suggestions that gluta-
mate may be involved in the aluminum-induced
neurocomplications. The excitotoxic effect of glutamate is
believed to be the cause of several neurodegenerative
processes [6] and several enzymes with the capacity to de-
grade glutamate have been suggested as possible neuro-
protectants [7]. It has been reported that aluminum
impairs the glutamatergic neurotransmission [8] and me-
diates glutamate-induced neurotoxicity in organotypic
cultures [9]. On the other hand, glutamate is an important
metabolic intermediate of the brain and it has potential
aluminum binding capacity [10]. In our earlier studies, we
have shown that aluminum causes alteration in glutamate
levels and glutamate α -decarboxylase activities of differ-
ent brain regions [11]. In addition to this, we had also
shown dietary protein restrictions to alter the aluminum-
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induced neurological responses in several brain regions
[3,12]. Thus the present investigation is aimed to study
the impact of aluminum as well as dietary protein restric-
tion on transaminases of the brain, which are related to
the glutamate metabolism.
Results
Body weights
The body weights of the rats during the period of treat-
ment (0–4th week) are presented in figure 1. A slightly
higher gain in body weight (on the 4th week) was ob-
served in the aluminum-treated rats of both the normal
and low protein dietary groups. However, these differenc-
es in body weight are not statistically significant. During
the course of the treatment, a decrement in food intake
was observed in the aluminum-treated rats of both dietary
groups (Figure 2).
Aluminum content
Changes in the aluminum content in different brain re-
gions on exposure to aluminum are given in table 1. The
present treatment increases the aluminum content of the
cerebrum, thalamic area, midbrain-hippocampal region
and cerebellum by 70.6%, 115.6%, 123.3% and 53.5% re-
spectively in normal protein-fed group of rats, whereas
59.4%, 93.3%, 107.7% and 53.2% respectively in low
protein-fed group of rats. Though there is significant
amount of added components for treatment effects in all
of the tested brain regions, Scheffe's F test for multiple
comparisons showed that aluminum exposure signifi-
cantly increased the aluminum content of cerebrum, tha-
lamic area and midbrain-hippocampal region of normal
protein group and thalamic area and midbrain-hippoc-
ampal region of rats maintained on low protein diet.
However, two factor ANOVA (with replication) showed
that only effects of aluminum treatment were significant
in all the four brain regions.
Glutamate oxaloacetate transaminase
The glutamate oxaloacetate transaminase (GOT) activities
of different brain regions of all groups of rats are present-
ed in table 2. The cerebrum, thalamic area, midbrain-hip-
pocampal region and cerebellum of low protein-fed group
of rats showed 9.7%, 17.9%, 20.8% and 13.6% increase in
GOT activities in response to aluminum exposure. On the
other hand, only the cerebellum of the normal protein-fed
group of rats showed 1.6% increase in GOT activity when
exposed to aluminum. Regional GOT activities of thalam-
ic area and midbrain-hippocampal region of rats main-
tained on normal protein diet were reduced by 10% and
11.5% respectively. Changes in the GOT activity of only
the cerebrum and midbrain-hippocampal regions of inad-
equately protein-fed rats were found to be statistically sig-
nificant by Scheffe's F test for multiple comparisons.
However, significant impacts of treatment were observed
in all the brain regions (ANOVA single factor). Two factor
Figure 1
Week wise body weight of rats during the period of treatment. Each data point represents the mean of six observations ± SEM.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/12
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ANOVA with replication showed that aluminum exposure
contributed significantly on the changes of the GOT activ-
ity of cerebellum only, but the interactions of impact of
dietary protein deficiency and aluminum exposure were
significant in thalamic area as well as midbrain-hippoc-
ampal region.
Figure 2
Week wise food intakes of rats during the period of treatment. Each data point represents the mean of six observations ± SEM.
Table 1: Regional aluminum content (µmoles / 100 mg tissue) in rat brain.
Brain regions Groups of animals Statistical calculation (F)
Normal protein Low protein ANOVA 
Single factor
ANOVA Two factors 
(with replication)
Control Aluminum 
exposed
Control Aluminum 
exposed
Cerebrum 2.86 ± 0.47 4.88 ± 0.44* 2.91 ± 0.54 4.64 ± 0.21 6.30 # Protein : 0.05 Aluminum : 18.75 # 
Interaction : 0.11
Thalamic area 4.16 ± 0.52 8.97 ± 0.71* 4.96 ± 0.42 9.59 ± 0.52* 24.69 # Protein : 1.65 Aluminum : 72.39 # 
Interaction : 0.03
Midbrain-hippocam-
pal region
4.17 ± 0.42 9.31 ± 0.62* 4.13 ± 0.25 8.58 ± 0.68* 28.47 # Protein : 0.55 Aluminum : 84.39# 
Interaction : 0.45
Cerebellum 3.10 ± 0.52 4.76 ± 0.64 2.82 ± 0.34 4.32 ± 0.44 3.56# Protein : 0.51 Aluminum : 10.14# 
Interaction : 0.03
Data are means of six observations ± SEM. * indicates significant difference (p < 0.05) in comparison to respective control. # indicates calculated F 
is higher than the critical F (α  = 0.05).BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/12
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Glutamate pyruvate transaminase
Table 3 represents the regional GPT activities of the differ-
ent groups of rats. Elevated activities of GPT were ob-
served in the cerebellum (24.6%), thalamic area (51.4%)
and cerebellum of aluminum-exposed animals of normal
protein-fed group. In the protein-restricted group, the
GPT activities were found to be increased in the cerebel-
lum (10.5%) and decreased in midbrain-hippocampal re-
gion (14%). Though a significant impact of treatments
were observed in all the brain regions except the cerebrum
(single factor ANOVA), only changes in the thalamic area
of normal protein diet group was found to significant by
Scheffe's F test. Two factor ANOVA (with replication)
showed that impact of aluminum is significant in thalam-
Table 2: Regional glutamate oxaloacetate transaminase activity (µg pyruvate produced / hr / mg tissue) in rat brain.
Brain regions Groups of animals Statistical calculation (F)
Normal protein Low protein ANOVA Sin-
gle factor
ANOVA Two factors 
(with replication)
Control Aluminum 
exposed
Control Aluminum 
exposed
Cerebrum 8.42 ± 0.37 8.38 ± 0.35 7.69 ± 0.25 8.44 ± 0.25* 9.03 # Protein : 1.14 Aluminum : 1.31 
Interaction : 1.62
Thalamic area 8.48 ± 0.16 7.64 ± 0.28 7.39 ± 0.32 8.71 ± 0.52 3.41 # Protein : 0.00 Aluminum : 0.49 
Interaction : 9.75 #
Midbrain-hippocam-
pal region
8.50 ± 0.18 7.52 ± 0.31 7.25 ± 0.27 8.76 ± 0.20* 9.03 # Protein : 0.00 Aluminum : 1.15 
Interaction : 25.95 #
Cerebellum 8.08 ± 0.25 8.21 ± 0.21 7.67 ± 0.23 8.71 ± 0.28 3.12# Protein : 0.04 Aluminum : 5.86# 
Interaction : 3.46
Data are means of six observations ± SEM. * indicates significant difference (p < 0.05) in comparison to respective control. # indicates calculated F 
is higher than the critical F (α  = 0.05).
Table 3: Regional glutamate pyruvate transaminase activity (µg pyruvate produced / hr / mg tissue) in rat brain.
Brain regions Groups of animals Statistical calculation (F)
Normal protein Low protein ANOVA 
Single factor
ANOVA Two factors 
(with replication)
Control Aluminum 
exposed
Control Aluminum 
exposed
Cerebrum 3.41 ± 0.21 4.25 ± 0.30 3.68 ± 0.25 3.69 ± 0.20 2.07 Protein : 0.35 Aluminum : 2.97 
Interaction : 2.88
Thalamic area 2.49 ± 0.19 3.77 ± 0.19* 3.41 ± 0.16 3.48 ± 0.18 9.23# Protein : 2.96 Aluminum : 13.78# 
Interaction : 10.96#
Midbrain-hippocam-
pal region
3.34 ± 0.19 3.34 ± 0.14 3.15 ± 0.07 2.71 ± 0.15 4.10# Protein : 7.71# Aluminum : 2.29 
Interaction : 2.29
Cerebellum 4.91 ± 0.09 5.43 ± 0.22 4.58 ± 0.10 5.06 ± 0.13 5.88# Protein : 5.84# Aluminum : 11.80# 
Interaction : 0.02
Data are means of six observations ± SEM. * indicates significant difference (p < 0.05) in comparison to respective control. # indicates calculated F 
is higher than the critical F (α  = 0.05).BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/12
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ic area and cerebellum, impact of protein restriction is sig-
nificant in midbrain-hippocampal region and
cerebellum, and the interaction of both protein restriction
and aluminum treatment is significant only in thalamic
area.
The correlations between the region wise changes in the
level of aluminum and activities of transaminases in re-
sponse to aluminum exposure (of both adequately pro-
tein-fed rats and inadequately protein-fed rats) have been
shown in table 4. Only significantly negative correlation
was observed between changes in aluminum level and al-
teration of GOT activities in adequately protein-fed group
of rats.
Discussion
Aluminum treatment of rats fed on either normal protein
or low protein diet increased the aluminum content in all
the brain regions. The midbrain-hippocampal region of
the aluminum-exposed rat brain showed highest level of
accumulation of aluminum. This observation is in agree-
ment with the available reports indicating hippocampus
to be the susceptible brain region for accumulation of alu-
minum [15–17]. However, the regional differences in in-
crement of aluminum level on exposure to aluminum are
comparable in both the dietary regimens. Protein defi-
ciency is not significantly impinging on regional alumi-
num level of brain (Table 1).
The observation that glutamate oxaloacetate transaminase
(GOT) is present in rat cerebral homogenate at about the
same concentrations as in liver suggests its importance in
the brain amino acid pool homeostasis [18]. The GOT ac-
tivity is found in both mitochondrial and soluble frac-
tions of the brain. The enzyme in mitochondria is latent
and can be 'activated' by various procedures that disrupt
the mitochondrial structure. The critical role of mitochon-
drial dysfunction in the pathogenesis of age-related nerve
cell degeneration has been suggested in several occasions
[19,20]. On the other hand, coexposure of aluminum and
glutamate is reported to produce morphological abnor-
malities of mitochondrial structures in pyramidal neurons
of hippocampal formation, which are not observed when
exposed to aluminum or glutamate alone [9]. Toninello et
al [21] also showed that aluminum is an inducer of mito-
chondrial permeability transition.
No significant change in GOT activity has been observed
in any of the brain regions in response to aluminum expo-
sure when the animals were maintained on normal pro-
tein diet. Favarato and Zatta [22] also did not observe any
alteration in serum GOT activity in response to alumi-
num. However, regional specificity was observed in alu-
minum-induced elevation of brain GOT activity, in the
inadequately protein-fed animals. Increased GOT activity
may be connected with an increased transport of NADH
from the cytosol to mitochondria [23]
In the present investigation the regional variation of nor-
mal GOT activity is not prominent but the response to
aluminum insult shows significant regional specificity.
Thus it may be suggested that aluminum exposure causes
region specific alteration in amino acid metabolism.
Hence, altered amino acid distribution pattern within the
brain might be expected in response to aluminum expo-
sure.
The observed region-specific alterations may also be at-
tributed to the level of accumulated aluminum in the re-
spective regions. Diencephalon is reported to be the most
vulnerable portion in case of accumulation in brain
[17,24], which is also observed in the present investiga-
tion (Table 1).
Though glutamate pyruvate transaminase (GPT) is indi-
cated to be distributed in both mitochondrial and soluble
fractions of the brain, unlike GOT, it is less active in brain.
However, Matthews et al [7] reported that both the en-
zymes degrade glutamate; though only GPT was able to re-
duce toxic (500 µM) levels of glutamate into the
physiologic (<20 µM) range. Our earlier observation
showed that aluminum exposure causes significant in-
crease in glutamate content in different regions of brain
while only thalamic area showed enhanced γ -amino bu-
tyrate content [11]. In the present investigation, the GPT
activity is increased only in thalamic area of sufficient pro-
tein-fed group. These observations support region-wise
specific sensitivity to aluminum exposure as indicated in
nucleic acid content and nucleic acid metabolism [3]. On
the other hand, in continuation with earlier studies [11] it
can be suggested that either the enhanced glutamate level
is not sufficient enough to trigger the response of GPT in
these regions or other removal pathway(s) are activated.
In addition to these, direct inhibition of GPT by alumi-
num and local concentration of pyruvate may also be in-
volved in the present observation of GPT activity. The
present investigation has revealed differential response of
Table 4: Correlation between regions of brain in terms of 
transaminase activity and aluminum content.
Correlation between Normal protein Low protein
Aluminum : GOT -1.00* 0.91
Aluminum : GPT 0.16 0.90
GOT : GPT -0.10 -0.60
* Indicates significant correlation (p < 0.05)BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/12
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enzymes in response to aluminum insult in various re-
gions of the brain. This finding corroborates with the ear-
lier observation of regional variation in enzyme activities
of brain in response to aluminum exposure [12,25].
These transaminase reactions are reversible, but the equi-
librium of the GOT and GPT reactions favour formation
of aspartate and alanine respectively [26]. Increased ami-
notransferase activities might participate in the enhanced
synthesis of excitatory amino acid neurotransmitters in
the nervous system [24].
Conclusions
These observations are suggestive of the fact that the me-
tabolism of the amino acids in response to aluminum ex-
posure is very much region specific. As amino acids in the
brain compose a major part of the neurotransmitters, it is
expected that, these alterations might also be involved in
the aluminum-induced neurobehavioral impairments.
These alterations are region specific and are dependent on
dietary protein intake or manipulation of the brain amino
acid homeostasis.
Methods
Animal maintenance and aluminum exposure
Male albino rats of Wistar strain weighing 100–120 g were
divided into four groups of almost equal average body
weight. The animals of two groups were maintained on
the diet containing 18% protein (casein) while the re-
maining two groups were maintained on 6% protein (ca-
sein) diet as reported earlier [3]. One group of rats from
each of the two dietary regimens received 4.2 mg /Kg body
weight / day as aluminum chloride intraperitoneally for
four weeks and the animals of the remaining groups serv-
ing as pair-fed controls received only the vehicle.
Tissue collection
After the period of treatment, overnight fasted rats were
sacrificed by cervical dislocation. The whole brain was re-
moved, washed with ice-cold saline, blotted dry and im-
mediately transferred to the ice chamber. Cerebrum,
thalamic area, midbrain-hippocampal region and cerebel-
lum were separated following of the dissection of the fro-
zen brain after thawing (making soft) in cold, under
dissecting microscope [3].
Biochemical estimation
The aluminum content of each tissue region was estimat-
ed by Atomic Absorption Spectrometer after digested with
acid mixture, containing nitric acid, sulphuric acid and
perchloric acid in the ratio of 6:1:1, over a regulated heater
[12]. The activities of glutamate oxaloacetate transami-
nase and glutamate pyruvate transaminase were measured
through spectrophotometric determination of 2,4 dinitro-
phenylhydrazone of pyruvate [13].
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